The DOI matches its Crossref record; 115 of the 116 references it cites were found in a registry or an index.
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Open accessAbstract
Although members of the fibroblast growth factor (FGF) family and their receptors have well-established roles in embryogenesis, their contributions to adult physiology remain relatively unexplored. Here, we use real-time quantitative PCR to determine the mRNA expression patterns of all 22 FGFs, the seven principal FGF receptors (FGFRs), and the three members of the Klotho family of coreceptors in 39 different mouse tissues. Unsupervised hierarchical cluster analysis of the mRNA expression data reveals that most FGFs and FGFRs fall into two groups the expression of which is enriched in either the central nervous system or reproductive and gastrointestinal tissues. Interestingly, the FGFs that can act as endocrine hormones, including FGF15/19, FGF21, and FGF23, cluster in a third group that does not include any FGFRs, underscoring their roles in signaling between tissues. We further show that the most recently identified Klotho family member, Lactase-like, is highly and selectively expressed in brown adipose tissue and eye and can function as an additional coreceptor for FGF19. This FGF atlas provides an important resource for guiding future studies to elucidate the physiological functions of FGFs in adult animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KLB expression is primarily restricted to specific metabolic tissues (for example, the liver, pancreas and adipose tissue)5, and lower expression is observed in the brain22,48–50. Despite some reports to the contrary51,52, KLB is not expressed in muscle5,41.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [5]
In the citing paper
“FGF21, unlike traditional FGFs, is an endocrine hormone produced and secreted predominantly by the liver [129,130].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationFibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S. C., Hu, M. C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,381
Self-citation
Flagged first, then by citations
1 of the 116 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 699
Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids
Zhang, J. H., Nolan, J., Kennie, S. L., Johnston, I. M., Dew, T. K., Dixon, P. H., Williamson, C., & Walters, J. R. F. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00398.2012 · Cited by 114
Zhang, C., Huang, Z., Gu, J., Yan, X., Lu, X., Zhou, S., Wang, S., Shao, M., Zhang, F., Cheng, P., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3630-8 · Cited by 113
Paracrine Effects of FGF23 on the Heart
Leifheit‐Nestler, M., & Haffner, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00278 · Cited by 110
Kolumam, G., Chen, M. Z., Tong, R., Zavala-Solorio, J., Kates, L., van Bruggen, N., Ross, J., Wyatt, S. K., Gandham, V. D., Carano, R. A. D., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.028 · Cited by 108
Geller, S., Arribat, Y., Netzahualcoyotzi, C., Lagarrigue, S., Carneiro, L., Zhang, L., Amati, F., López‐Mejía, I. C., & Pellerin, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.004 · Cited by 117
The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol
Song, P., Zechner, C., Hernandez, G., Canovas, J. A., Xie, Y., Sondhi, V., Wagner, M., Stadlbauer, V., Horvath, A., Leber, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.001 · Cited by 103
Self-citationFGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis
Ji, S., Liu, Q., Zhang, S., Chen, Q., Wang, C., Zhang, W., Chen, X., Li, Y., Nian, C., Li, J., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.021 · Cited by 106
Self-citationFGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
Sonoda, J., Chen, M. Z., & Baruch, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0002 · Cited by 110
Li, S., Zhu, Z., Xue, M., Yi, X., Liang, J., Niu, C. S., Chen, G., Shen, Y., Zhang, H., Jiayong, Z., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.019 · Cited by 107
Harrison, S. A., Frías, J. P., Lucas, K. J., Reiss, G. M., Neff, G. W., Bollepalli, S., Su, Y., Chan, D. C., Tillman, E. J., Moulton, A. W., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.02.022 · Cited by 117
The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology
Mencke, R., & Hillebrands, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.001 · Cited by 104
Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
Zhou, M., Luo, J., Chen, M., Yang, H., Learned, R. M., DePaoli, A. M., Tian, H., & Ling, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.027 · Cited by 102
Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
Markan, K. R., & Potthoff, M. J. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.09.021 · Cited by 103
Circadian control of bile acid synthesis by a KLF15-Fgf15 axis
Han, S., Zhang, R., Jain, R., Shi, H., Zhang, L., Zhou, G., Sangwung, P., Tugal, D., Atkins, G. B., Prosdocimo, D. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8231 · Cited by 102
Glucocorticoids Regulate the Metabolic Hormone FGF21 in a Feed-Forward Loop
Patel, R., Bookout, A. L., Magomedova, L., Owen, B. M., Consiglio, G. P., Shimizu, M., Zhang, Y., Mangelsdorf, D. J., Kliewer, S. A., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1259 · Cited by 102
Self-citationDistinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
Xiao, Y., Xu, A., Law, L. S., Chen, C., Li, H., Li, X., Yang, L., Liu, S., Zhou, Z., & Lam, K. S. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1930 · Cited by 102
The FGF21–adiponectin axis in controlling energy and vascular homeostasis
Hui, X. H., Feng, T., Liu, Q., Gao, Y., & Xu, A. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw013 · Cited by 103
Peripherally derived FGF21 promotes remyelination in the central nervous system
Kuroda, M., Muramatsu, R., Maedera, N., Koyama, Y., Hamaguchi, M., Fujimura, H., Yoshida, M., Konishi, M., Itoh, N., Mochizuki, H., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94337 · Cited by 101
Zhang, C., Shao, M., Yang, H., Chen, L., Yu, L., Cong, W., Tian, H., Zhang, F., Cheng, P., Jin, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082275 · Cited by 100
Fibroblast growth factor 21 night watch: advances and uncertainties in the field
Kharitonenkov, A., & DiMarchi, R. D. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12580 · Cited by 97
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
Czaya, B. A., & Faul, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174195 · Cited by 101
Restelli, L. M., Oettinghaus, B., Halliday, M., Ağca, C., Licci, M., Sironi, L., Savoia, C., Hench, J., Tolnay, M., Neutzner, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.023 · Cited by 98
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Zhu, Y., Prata, L. G. P. L., Gerdes, E. O. W., Netto, J. M. E., Pirtskhalava, T., Giorgadze, N., Tripathi, U., Inman, C. L., Johnson, K. O., Xue, A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103912 · Cited by 100
Henriksson, E., & Andersen, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.601349 · Cited by 97
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
Cicione, C., Degirolamo, C., & Moschetta, A. (2012) · Hepatology · doi:10.1002/hep.25929 · Cited by 95
Wu, S., Levenson, A. E., Kharitonenkov, A., & Luca, F. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.343707 · Cited by 94
KLB, encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
Xu, C., Messina, A., Somm, E., Miraoui, H., Kinnunen, T. K., Acierno, J. S., Niederländer, N. J., Bouilly, J., Dwyer, A. A., Sidis, Y., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607376 · Cited by 98
Self-citationFibroblast-mediated pathways in cardiac hypertrophy
Fujiu, K., & Nagai, R. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.013 · Cited by 97
Ijssennagger, N., Janssen, A. W. F., Milona, A., Pittol, J. M. R., Hollman, D. A. A., Mokrý, M., Betzel, B., Berends, F. J., Janssen, I. M. C., van Mil, S. W. C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.016 · Cited by 94
Ye, L., Wang, X. B., Cai, C., Zeng, S., Bai, J., Guo, K., Fang, M., HU, J. L., Liu, H., Zhu, L., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.013 · Cited by 93
Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle
Vandanmagsar, B., Warfel, J. D., Wicks, S. E., Ghosh, S., Salbaum, J. M., Burk, D., Dubuisson, O. S., Mendoza, T. M., Zhang, J., Noland, R. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.057 · Cited by 92
FGF23-αKlotho as a paradigm for a kidney-bone network
Kuro‐o, M., & Moe, O. W. (2016) · Bone · doi:10.1016/j.bone.2016.11.013 · Cited by 93
Self-citationTargeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
Zarei, M., Pizarro‐Delgado, J., Barroso, E., Palomer, X., & Vázquez‐Carrera, M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.12.005 · Cited by 92
FGF21 in obesity and cancer: New insights
Lu, W., Li, X., & Luo, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.026 · Cited by 93
Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease
Itoh, N., Nakayama, Y., & Konishi, M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00030 · Cited by 94
Li, S., Hsu, D. D., Li, B., Luo, X., Alderson, N. B., Qiao, L., Ma, L., Zhu, H. H., He, Z., Suino-Powell, K. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.020 · Cited by 91
Plasma FGF21 Is Elevated by the Intense Lipid Mobilization of Lactation
Schoenberg, K. M., Giesy, S. L., Harvatine, K. J., Waldron, M. R., Cheng, C., Kharitonenkov, A., & Boisclair, Y. R. (2011) · Endocrinology · doi:10.1210/en.2011-1425 · Cited by 90
Jiang, X. M., Zhang, C., Xin, Y., Huang, Z., Tan, Y., Huang, Y., Wang, Y., Feng, W., Li, X., Li, W., et al. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.022 · Cited by 88
Luo, Y., Yang, Y., Liu, M., Wang, D., Wang, F., Bi, Y., Ji, J., Li, S., Liu, Y., Chen, R., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.030 · Cited by 87
Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges
Martínez‐Garza, Ú., Torres‐Oteros, D., Yarritu, A., Marrero, P. F., Haro, D., & Relat, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194692 · Cited by 88
Hepatokines and non-alcoholic fatty liver disease
Lebensztejn, D. M., Flisiak-Jackiewicz, M., Białokoz-Kalinowska, I., Bobrus-Chociej, A., & Kowalska, I. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1252 · Cited by 90
“FGF-21 is a 209 amino acid peptide produced mainly in the liver, but the expression of this protein in the lower extent was also found in the pancreas, testes, duodenum and adipose tissue; gene for FGF-21 is localized on chromosome 19 (Nishimura et al., 2000; Fon Tacer et al., 2010; Li et al., 2013).”
BackgroundFibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 85
Murata, Y., Konishi, M., & Itoh, N. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/981315 · Cited by 87
FGF 21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
Yan, X., Chen, J., Zhang, C., Zhou, S., Zhang, Z., Chen, J., Feng, W., Li, X., & Tan, Y. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12530 · Cited by 85
Chou, R., Huang, P., Hsu, C., Chang, C. C., Leu, H., Huang, C., Chen, J., & Lin, S. (2016) · Scientific Reports · doi:10.1038/srep33953 · Cited by 82
FGF19 and FGF21: In NASH we trust
Talukdar, S., & Kharitonenkov, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101152 · Cited by 82
Jacky, B., Garay, P. E., Dupuy, J., Nelson, J. B., Cai, B. B., Molina, Y., Wang, J., Steward, L. E., Broide, R. S., Francis, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003369 · Cited by 84
Kuro‐o, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_2 · Cited by 80
Self-citationKuro-o, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy126 · Cited by 80
Self-citationEffect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79
Liu, Y., Zhao, C., Xiao, J., Liu, L., Zhang, M., Wang, C., Wu, G., Zheng, M.-H., Xu, L.-M., Chen, Y.-P., et al. (2016) · Scientific Reports · doi:10.1038/srep31026 · Cited by 78
Self-citationAraki, M., Nakagawa, Y., Oishi, A., Han, S., Wang, Y., Kumagai, K., Ohno, H., Mizunoe, Y., IWASAKI, H. O., Sekiya, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072148 · Cited by 82
Jackson, T. C., & Kochanek, P. M. (2019) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2019.0001 · Cited by 77
Hoang, T. V., Kumar, P., Sreeskandarajan, S., Tsonis, P. A., Liang, C., & Robinson, M. L. (2014) · Europe PMC (PubMed Central) · Cited by 77
Omar, B. A., Andersen, B., Hald, J., Raun, K., Nishimura, E., & Åhrén, B. (2013) · Diabetes · doi:10.2337/db13-0710 · Cited by 76
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
Lakhani, I., Gong, M., Wong, W. T., Bazoukis, G., Lampropoulos, K. M., Wong, S. H., Wu, W. K. K., Wong, M. C. S., Ong, K. L., Liu, T., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.017 · Cited by 76
Pathophysiology of NASH in endocrine diseases
Gariani, K., & Jornayvaz, F. R. (2021) · Endocrine Connections · doi:10.1530/ec-20-0490 · Cited by 77
FGF21 reverses MASH through coordinated actions on the CNS and liver
Rose, J. P., Morgan, D. A., Sullivan, A. I., Fu, X., Inigo-Vollmer, M., Burgess, S. C., Meyerholz, D. K., Rahmouni, K., & Potthoff, M. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.014 · Cited by 75
Hensel, N., Schön, A., Konen, T., Lübben, V., Förthmann, B., Baron, O., Grothe, C., Leifheit‐Nestler, M., Claus, P., & Haffner, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13585 · Cited by 78
Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers
Andersen, B., Beck‐Nielsen, H., & Højlund, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04084.x · Cited by 74
Audette, D. S., Anand, D., So, T., Rubenstein, T., Lachke, S. A., Lovicu, F. J., & Duncan, M. K. (2015) · Development · doi:10.1242/dev.127860 · Cited by 74
Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
Zhang, J., & Li, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.021 · Cited by 73
Khosravi, F., Ahmadvand, N., Bellusci, S., & Sauer, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672935 · Cited by 78
The potential function and clinical application of FGF21 in metabolic diseases
Chen, Z., Yang, L., Liu, Y., Huang, P., Song, H., & Zheng, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1089214 · Cited by 73
The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension
Huang, Z. P., Xu, A., & Cheung, B. M. Y. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0730-5 · Cited by 71
Rader, D. J., Maratos-Flier, E., Nguyen, A., Hom, D., Ferriere, M., Li, Y., Kompa, J., Martic, M., Hinder, M., Basson, C. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab624 · Cited by 72
Samms, R. J., Cheng, C. C., Kharitonenkov, A., Gimeno, R. E., & Adams, A. C. (2016) · Endocrinology · doi:10.1210/en.2015-1722 · Cited by 76
Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects
Lei, Y., Wang, L., Guo, K., Hou, Y., Li, N., Wang, S., Liu, X., Zhao, Q., Zhou, J., Zhao, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27584-y · Cited by 74
Self-citationDecline in muscle strength and running endurance in klotho deficient C57BL/6 mice
Phelps, M., Pettan-Brewer, C., Ladiges, W., & Yablonka‐Reuveni, Z. (2013) · Biogerontology · doi:10.1007/s10522-013-9447-2 · Cited by 69
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling
Li, G., Shao, Y., Guo, H. C., Zhi, Y., Qiao, B., Ma, K., Du, J., Lai, Y. Q., & Li, Y. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab248 · Cited by 72
Spann, R. A., Morrison, C. D., & den Hartigh, L. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.802541 · Cited by 76
Adiponectin Deficit During the Precarious Glucose Economy of Early Lactation in Dairy Cows
Giesy, S. L., Yoon, B., Currie, W. B., Kim, J. W., & Boisclair, Y. R. (2012) · Endocrinology · doi:10.1210/en.2012-1765 · Cited by 75
Saucedo, L., Buffa, G. N., Rosso, M., Guillardoy, T., Góngora, A., Munuce, M. J., Vazquez-Levin, M. H., & Marín-Briggiler, C. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127297 · Cited by 70
Ciaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 76
Nygaard, E., Møller, C. L., Kievit, P., Grove, K. L., & Andersen, B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.79 · Cited by 69
Kawakami, K., Takeshita, A., Furushima, K., Miyajima, M., Hatamura, I., Kuro‐o, M., Furuta, Y., & Sakaguchi, K. (2017) · Scientific Reports · doi:10.1038/srep40534 · Cited by 69
Self-citationKruse, R., Vienberg, S. G., Vind, B. F., Andersen, B., & Højlund, K. (2017) · Diabetologia · doi:10.1007/s00125-017-4373-5 · Cited by 69
Fibroblast growth factor-21 controls dietary protein intake in male mice
Larson, K. R., Chaffin, A. T.-B., Goodson, M. L., Fang, Y., & Ryan, K. K. (2019) · Endocrinology · doi:10.1210/en.2018-01056 · Cited by 68
Functional Implications of DNA Methylation in Adipose Biology
Ma, X., & Kang, S. (2019) · Diabetes · doi:10.2337/dbi18-0057 · Cited by 69
Biomarkers of mitochondrial disorders
Shayota, B. J. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00325 · Cited by 82
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Markan, K. R., Naber, M. C., Small, S. M., Peltekian, L., Kessler, R. L., & Potthoff, M. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.03.009 · Cited by 70
Weng, Y., Chabot, J., Bernardo, B. L., Yan, Q., Zhu, Y., Brenner, M. B., Vage, C., Logan, A., Calle, R. A., & Talukdar, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119104 · Cited by 67
Potential roles of fibroblast growth factor 21 in the brain
Sa‐nguanmoo, P., Chattipakorn, N., & Chattipakorn, S. C. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-015-9789-3 · Cited by 70
The FGF21 Receptor Signaling Complex
Kilkenny, D. M., & Rocheleau, J. V. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.008 · Cited by 68
Tanycytes As Regulators of Seasonal Cycles in Neuroendocrine Function
Lewis, J. E., & Ebling, F. J. P. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00079 · Cited by 67
Pan, Y., Wang, B., Zheng, J., Xiong, R., Fan, Z., Ye, Y., Zhang, S., Li, Q., Gong, F., Wu, C., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14007 · Cited by 67
Lindner, M., Thümmler, K., Arthur, A. T., Brunner, S. P., Elliott, C., McElroy, D., Mohan, H., Williams, A., Edgar, J. M., Schuh, C., et al. (2015) · Brain · doi:10.1093/brain/awv102 · Cited by 67
Role of fibroblast growth factor signalling in hepatic fibrosis
Seitz, T., & Hellerbrand, C. (2021) · Liver International · doi:10.1111/liv.14863 · Cited by 64
Andersen, B., Straarup, E. M., Heppner, K. M., Takahashi, D. L., Raffaele, V., Dissen, G. A., Lewandowski, K., Bödvarsdottir, T. B., Raun, K., Grove, K. L., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0080-7 · Cited by 66
Hultman, K., Scarlett, J. M., Baquero, A. F., Cornea, A. M., Zhang, Y., Salinas, C. B. G., Brown, J. M., Morton, G. J., Whalen, E. J., Grove, K. L., et al. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24668 · Cited by 65
Increased FGF21 plasma levels in humans with sepsis and SIRS
Gariani, K., Drifte, G., Dunn-Siegrist, I., Pugin, J., & Jornayvaz, F. R. (2013) · Endocrine Connections · doi:10.1530/ec-13-0040 · Cited by 65
Schumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 64
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
Aaldijk, A. S., Verzijl, C. R. C., Jonker, J. W., & Struik, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150222 · Cited by 63
Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
Matsumoto, E., Sasaki, S., Kinoshita, H., Kito, T., Ohta, H., Konishi, M., Kuwahara, K., Nakao, K., & Itoh, N. (2013) · Genes to Cells · doi:10.1111/gtc.12055 · Cited by 65
Metformin Stimulates FGF21 Expression in Primary Hepatocytes
Nygaard, E. B., Vienberg, S. G., Ørskov, C., Hansen, H. S., & Andersen, B. (2012) · Experimental Diabetes Research · doi:10.1155/2012/465282 · Cited by 62
Cardiac actions of fibroblast growth factor 23
Faul, C. (2016) · Bone · doi:10.1016/j.bone.2016.10.001 · Cited by 64
Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues
Lin, X., Liu, Y. B., & Hu, H. (2017) · Biomedical Reports · doi:10.3892/br.2017.890 · Cited by 61
Miyake, M., Nomura, A., Ogura, A., Takehana, K., Kitahara, Y., Takahara, K., Tsugawa, K., Miyamoto, C., Miura, N., Sato, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-275990 · Cited by 62
Nrf2 induces fibroblast growth factor 21 in diabetic mice
Furusawa, Y., Uruno, A., Yagishita, Y., Higashi, C., & Yamamoto, M. P. (2014) · Genes to Cells · doi:10.1111/gtc.12186 · Cited by 62
Rodelo‐Haad, C., Santamaría, R., Muñoz-Castañeda, J. R., de Mier, M. V. P.-R., Martín‐Malo, A., & Rodríguez, M. (2019) · Toxins · doi:10.3390/toxins11030175 · Cited by 62
Metadata
- Authors
- Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., & Kliewer, S. A.
- Affiliations
- Department of Molecular Biology (K.F.T., X.D., S.A.K.), Dallas, Texas 75390
- Howard Hughes Medical Institute (US)
- Department of Pathology (H.K., G.B.J., L.W., M.K.), Dallas, Texas 75390
- New York University (US)
- Corresponding author
- Mangelsdorf, David J.
- Kliewer, Steven A.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-10-01
- Volume
- 24
- Issue
- 10
- Pages
- 2050-2064
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC2954642
- OpenAlex
- W1968091833
- Cited by
- 700
- References
- 116
- Citations by year
- 2026: 22 · 2025: 38 · 2024: 46 · 2023: 48 · 2022: 53 · 2021: 68 · 2020: 52 · 2019: 64 · 2018: 55 · 2017: 41 · 2016: 45 · 2015: 53 · 2014: 28 · 2013: 32 · 2012: 35
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute (I-1558, I-1275)
- Welch Foundation (I-1275, I-1558, GM007062)
- National Institutes of Health (I-1275, I-1558, DK067158, U19DK62434, AG19712)
- National Institute on Aging (AG-19712, R01AG019712)
- National Institute of General Medical Sciences (T32GM007062, GM007062, RL1GM084436)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, U19 DK-62434, U19DK062434, R01DK067158)
- National Institute of Dental and Craniofacial Research (DE13686, R01DE013686)
- National Center for Research Resources (P20RR20691, P20RR020691)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- fibroblast growth factor, fibroblast growth factor receptor, FGF19, FGF21, fibroblast growth factor 23, FGF15/19, tissue-specific gene expression, adult mice, brown adipose tissue, hormone signaling, central nervous system
- MeSH terms
- Fibroblast Growth Factor-23, Animals, Atlases as Topic, Fibroblast Growth Factors, Humans, Mice, Inbred C57BL, RNA, Messenger, Tissue Distribution, Cluster Analysis, Receptors, Fibroblast Growth Factor, Gene Expression Profiling, Microarray Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
